Johnson & Johnson: A Safe Hold, But Lacking Catalysts To Beat The Market

Johnson & Johnson's business is in a stable, mature phase, suggesting slow yet steady growth. Click here to read why JNJ stock is a Hold.
katc

Johnson & Johnson vaccine: FDA report finds single-shot vaccine to be safe, effective

An FDA report released Wednesday indicates that Johnson & Johnson’s single-shot COVID-19 vaccine is safe and effective, setting the stage for its potential approval and distribution in the coming days ...